ArticleEuropean journal of drug metabolism and pharmacokinetics

The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.

Gary W Caldwell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.